Peter Lamb, EVP, Scientific Strategy & CSO at EXELIXIS, INC. (EXEL), sold 109,663 shares at $18.09 ($2.0M) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Seasonal sale ($2.0M) by EVP, Scientific Strategy & CSO — this insider has traded EXEL in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.09 | 47,500 | $859K | 43.3% |
| 2 | $18.10 | 2,323 | $42K | 2.1% |
| 3 | $18.10 | 6,818 | $123K | 6.2% |
| 4 | $18.10 | 53,022 | $960K | 48.4% |
| Total | $18.10 avg | 109,663 | $2.0M | 100% |
| Filing → |
| EXEL | SELL | 2021-10-15 | $2.1M | — | Filing → |
| EXEL | SELL | 2021-09-17 | $972K | — | Filing → |
| EXEL | SELL | 2021-08-18 | $2.0M | — | Filing → |